Hologic, Inc.
HOLX
NASDAQ·Healthcare·Medical - Instruments & Supplies·Mkt cap $17.0B
$76.01
▲ 0.00%
P/E
31.67
Mkt Cap
$17.0B
52-Wk Range
$51.90–$76.07
52-Week Range
$51.90 - $76.07
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 37.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Advanced proprietary medical technologies
- Comprehensive women's health product portfolio
- Strong research and development capabilities
- Established global distribution networks
Bear Case
1 risk
- Low volatility (beta 0.7).
Growth
Stable outlook
Increasing global healthcare technology investments
Value
Attractively priced below Medical Devices peer average
Momentum
Stable
+1.6% over 3m
Quality
Strong
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying HOLX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Most recent quarter reported revenue of $1.0B (+3% YoY). Reported EPS of $0.80. Gross margin 56.0%.
Reported EPS · last 4Q
Q1 25
$0.80
Q4 25
$0.84
Q3 25
$0.87
Q2 25
-$0.08
Revenue trend · last 8Q
—
—
—
+1%
-1%
+1%
+6%
+3%
Q2 24
Q3 24
Q4 24
Q1 24
Q2 25
Q3 25
Q4 25
Q1 25
$1.0B
$1.0B
$988.0M
$1.0B
$1.0B
$1.0B
$1.0B
$1.0B
Margins · last 8Q
Gross
56.0%
Operating
22.6%
Profit
17.1%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How HOLX stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related